Carol Pollock
Carol Pollock is a medical researcher specialising in kidney health and disease. She is a Clinical Professor of Medicine at the University of Sydney, Northern Clinical School, Kolling Institute of Medical Research. Her research interests also include obesity, diabetes, cardiovascular disease, healthy ageing and lifespan, employing animal models and cellular and molecular techniques. She is the Chair of Kidney Health Australia and was the Chair of Medicine Royal North Shore Hospital in 2011 to 2016. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Carol Pollock', query time: 0.06s
Refine Results
-
1
Mesenchymal Stem Cell-Derived Extracellular Vesicles to the Rescue of Renal Injury by Lucy Birtwistle, Xin-Ming Chen, Carol Pollock
Published 2021-06-01
Article -
2
-
3
Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE by Giulia Ferrannini, Carol Pollock, Andrea Natali, Yshai Yavin, Kenneth W. Mahaffey, Ele Ferrannini
Published 2023-04-01
Article -
4
Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications by Carol Pollock, Magdalena Madero, Sungjin Chung, Yau-Jiunn Lee, Mustafa Arici, Samir Helmy Assaad-Khalil, Marcello Casaccia Bertoluci, Guillermo Javier Rosa Diez, Vicente Sánchez Polo, Teerawat Thanachayanont
Published 2024-03-01
Article -
5
Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the D... by Akihiko Koshino, Brendon L. Neuen, Niels Jongs, Carol Pollock, Peter J. Greasley, Eva-Marie Andersson, Ann Hammarstedt, Cecilia Karlsson, Anna Maria Langkilde, Takashi Wada, Hiddo J.L. Heerspink
Published 2023-11-01
Article -
6
Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials by Robert A. Fletcher, Clare Arnott, Patrick Rockenschaub, Aletta E. Schutte, Lewis Carpenter, Muthiah Vaduganathan, Rajiv Agarwal, George Bakris, Tara I. Chang, Hiddo J. L. Heerspink, Meg J. Jardine, Kenneth W. Mahaffey, Bruce Neal, Carol Pollock, Min Jun, Anthony Rodgers, Vlado Perkovic, Brendon L. Neuen
Published 2023-07-01
Article -
7
Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering by Bernard Zinman, Bruce Neal, George L Bakris, Vlado Perkovic, Meg J Jardine, Kris Rogers, Jie Yu, Adeera Levin, Dick de Zeeuw, Hong Zhang, Kenneth W Mahaffey, Clare Arnott, Rajiv Agarwal, Gian Luca Di Tanna, Carol Pollock, David C Wheeler, Christopher P Cannon, David M Charytan, Hiddo J Lambers Heerspink, Norman Rosenthal
Published 2023-05-01
Article -
8
Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial by Jing‐Wei Li, Clare Arnott, Hiddo J. L. Heerspink, Qiang Li MBiostat, Christopher P. Cannon, David C. Wheeler, David M. Charytan, Jennifer Barraclough, Gemma A. Figtree, Rajiv Agarwal, George Bakris, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, Hong Zhang, Bernard Zinman, Kenneth W. Mahaffey, Vlado Perkovic, Bruce Neal, Meg J. Jardine
Published 2022-08-01
Article